Biotechnology News and Research

RSS

New possibilities for the use of VEGF in the treatment of Amyotrophic Lateral Sclerosis

ALS is an incurable, paralyzing neurodegenerative disorder that strikes 5 persons in every 100,000. The disease commonly affects healthy people in the most active period of their lives − without warning or previous family history.

29 Nov 2004

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Manufacturers in the crowded and highly fragmented European active pharmaceutical ingredients (API) market are struggling to overcome a variety of challenges. One of the most pressing of these is the problem of overcapacity.

29 Nov 2004

Discovery of a new cancer gene, which, when damaged, may promote prostate cancer

Together with an international research team, researchers from VTT Technical Research Centre of Finland have developed an effective method for the screening and identification of genes that under normal conditions suppress cancer growth.

24 Nov 2004

Breakthrough HIV research wins prestigious industry award

Research that could lead to a breakthrough in the treatment of HIV has scooped a University of Manchester scientist a prestigious industry award.

From The University of Manchester 23 Nov 2004

Vaccinex and Biocon to co-develop at least four therapeutic antibody products

The collaboration combines Vaccinex's unique capabilities to discover fully human monoclonal antibodies using its proprietary antibody discovery technology and Biocon's proven expertise in clinical research and biologics manufacturing.

19 Nov 2004

Transport route explain why peanuts are one of the most allergenic foods

A UK scientist has discovered the route and type of transport taken by peanut proteins through the gut to the immune system. This route favours an immune response, which helps explain why peanuts are one of the most allergenic foods.

18 Nov 2004

Scientists enticed back to Australia to tackle major health challenges

CSIRO and the Queensland Government are attracting leading overseas-based Australian scientists to return to work on major health challenges at the e-health Research Centre in Brisbane.

8 Nov 2004

The first test in humans of a bioartificial kidney

The first test in humans of a bioartificial kidney offers hope of the device's potential to save the lives of people with acute renal failure, researchers at the University of Michigan Health System report.

4 Nov 2004

Researchers find that berries inhibit growth of harmful intestinal bacteria

A research project carried out by VTT Biotechnology and the University of Helsinki has found that cloudberries and raspberries contain a phenol, ellagic tannin, that inhibits the growth of intestinal bacteria.

2 Nov 2004

Scientists identify crucial elements necessary for repairing damaged DNA

A team of University of Sussex-led scientists has identified crucial elements necessary for repairing damaged DNA - the blueprint for all living cells.

25 Oct 2004

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

A UK vaccine technology that is set to revolutionise the industry has received £950k funding from the Department for International Development (DFID) to bring to production a pentavalent childhood vaccine that can be stored without refrigeration.

25 Oct 2004

BMA report hopes to raise awareness about the threat of biological weapons

A new report released today (25 October 2004) by the BMA paints a bleak picture of the global community's ability to cope with advances in biological and genetic weapons technology.

25 Oct 2004

Research opens new possibilities for the treatment of metabolic disorders such as diabetes and obesity

For the first time, researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected with the Catholic University of Leuven have shown clearly that receptors in yeast cells detect and react to nutrients in the cell.

21 Oct 2004

UniSA to officially open its Nano and Bio Materials Centre

Some of the greatest wonders of the 21st century will probably occur on a small scale – in fact a tiny scale – smaller than a human blood cell, right down there at the level of atoms and molecules.

19 Oct 2004

Researchers have developed a novel drug-antidote pair

In a discovery that could give physicians more control over the actions of medications, researchers at Duke University Medical Center have developed a novel drug pair – a potent anti-coagulant with a matched "antidote."

18 Oct 2004

Genetic science gaining momentum by silencing genes

Along with five European academic laboratories, researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to Ghent University are accelerating the study of the model plant Arabidopsis thaliana.

16 Oct 2004

One of the largest studies in the world looking at how caffeine in our diet may affect health

The study is particularly important because caffeine, found mainly in coffee, tea and cola, is 'the most widely consumed drug in the world', yet little is known about the amount of caffeine consumed in the UK and the implications for health.

12 Oct 2004

Results of nationwide survey of Americans’ attitudes toward stem-cell research, cloning and other scientific and medical advances

Virginia Commonwealth University on Wednesday, Oct. 13, will release the results of its annual nationwide survey of Americans’ attitudes toward stem-cell research, cloning and other scientific and medical advances in technology.

11 Oct 2004

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

United States Department of Health and Human Services has announced four new contracts totaling more than $232 million to fund development of new vaccines against three potential agents of bioterrorism: smallpox, plague and tularemia. The National Institute of Allergy and Infectious Diseases (NIAID), will administer the contracts.

8 Oct 2004

Understanding how microbes in the gut interact with the body could lead to new a understanding and novel treatments for diseases

Understanding how microbes in the gut interact with the body could lead scientists and doctors to new a understanding and novel treatments for diseases say scientists from Imperial College London and Astra Zeneca.

6 Oct 2004

Biotechnology News and Research

New possibilities for the use of VEGF in the treatment of Amyotrophic Lateral Sclerosis

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Discovery of a new cancer gene, which, when damaged, may promote prostate cancer

Breakthrough HIV research wins prestigious industry award

Vaccinex and Biocon to co-develop at least four therapeutic antibody products

Transport route explain why peanuts are one of the most allergenic foods

Scientists enticed back to Australia to tackle major health challenges

The first test in humans of a bioartificial kidney

Researchers find that berries inhibit growth of harmful intestinal bacteria

Scientists identify crucial elements necessary for repairing damaged DNA

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

BMA report hopes to raise awareness about the threat of biological weapons

Research opens new possibilities for the treatment of metabolic disorders such as diabetes and obesity

UniSA to officially open its Nano and Bio Materials Centre

Researchers have developed a novel drug-antidote pair

Genetic science gaining momentum by silencing genes

One of the largest studies in the world looking at how caffeine in our diet may affect health

Results of nationwide survey of Americans’ attitudes toward stem-cell research, cloning and other scientific and medical advances

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

Understanding how microbes in the gut interact with the body could lead to new a understanding and novel treatments for diseases

Biotechnology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News